Objective analytical goals for interference in clinical biochemical methods have not yet been advocated. We propose that, since total analytical error is ideally less than half the within-subject biological coefficient of variation (CV,), the maximum allowable systematic error produced by an interferent ( I ) is:
Interference is the effect of a component, which does not by itself produce a reading, on the accuracy of measurement of another component; it results in low (inhibition) or high (enhancement) values.' However, although the many published protocols for the evaluation of instruments, reagent kit sets and methods describe the means by which interference can be determined quantitatively, there are few guidelines on analytical goals, that is the performance standards which are desirable to attain to facilitate the provision of optimal patient care.
Guidelines on the evaluation of analytical interference have been published by the International Federation of Clinical Chemistry (IFCC),2 the International Union of Pure and Applied Chemistry (IUPAC),3 the Societt Francaise de Biologie Clinique (SFBC)4 and the National Committee for Clinical Laboratory Standards (NCCLS) of the USA. 5 it is considered that a quantity produces an analytical interference if Student's t-test for paired data, or Wilcoxon's T-test, show significant differences (P<O.Ol) between the results obtained in the presence and absence of the interfering quantity in the specimens assayed. It follows that, if the number of data points is large enough, it is In the IFCC and the SFBC Correspondence: Dr X Fuentes-Arderiu. possible to demonstrate small differences which, although statistically significant, might not affect the clinical interpretation of results.
The NCCLS recommendations state that the degree of interference that is acceptable must be decided through consideration of the medical req~irements.~ However, it is stated that, in the absence of other guidelines, if the found effect falls within the between-run analytical imprecision, and the incremental error caused by the potential interferent is not large enough to affect clinical decision making, the problem should be considered as irrelevant in practice; as a rule of thumb, use of one between-run standard deviation was recommended.
The IUPAC document defines the concept of interfering substance in analytical procedure^.^ Here, it is strongly recommended that a substance should be considered as an interferent if it causes a systematic error greater than three standard deviations of an unequivocally defined set of results obtained with the analytical procedure. However, this recommendation does not consider clinical requirements, probably because it is not intended solely for clinical biochemistry.
In consequence, these published criteria do not seem to offer an acceptable or objective goal for interference in clinical biochemical methods. It is important that objective criteria for acceptability be set before any evaluation is undertaken and 393
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data analysis performed. Accordingly, a strategy to develop an analytical goal for interference in clinical chemistry was developed and is proposed here.
THEORY
The rationale for establishing the analytical goal is based on the concepts of total error and total allowable error,6 and on knowledge of the within-subject biological variation of clinical biochemical quantities.
The total error ( T E ) of a system of measurement is defined as the maximum absolute error for 95% of measurements carried out on specimens from patients.' According to Westgard et ~l . ,~ total error (TE) is random error ( R E ) plus systematic error (SE) and TE should be less than the total allowable error (E,). Since evaluation experiments are performed at a variety of different levels of quantity, we shall express errors in terms of relative standard deviation, i.e., coefficient of variation (CV). Thus,
TE=1.96 C V , + S E < E ,
where CV, is the relevant experimentally derived analytical imprecision.B CV, should be selected as either within-run or between-run imprecision depending on the actual protocol used in the evaluation experiments to determine the effect of a possible interferent.
It is generally acceptedg-I2 that, at present, the analytical goal for imprecision is that it should be less than or equal to half the within-subject biological variation (CV,); achievement means that test result variability is made only ca 10% greater through analytical variation. Moreover, it is widely recognizedI0-l2 that the ideal is that methods should have no systematic error so that results are comparable over time and locale and can be interpreted against fixed national or international c rite ria.^ Thus, V , -(1.96 C V , + S E ) 
DISCUSSION
The goal derived by using this approach depends on within-subject biological variation and the relevant experimentally derived imprecision and systematic error. The model is simple to apply since there are many data on within-subject variation. I2-I4
Some do not accept that the goal for total error should be based upon within-subject biological ~a r i a t i 0 n . I~ This does not render the model inappropriate. If they could be justified objectively, other goals based upon, for example, the strategy recently proposed to set goals for use in specific clinical monitoring situations,I6 could be substituted for CVI in the above formula, if it was considered most appropriate.
It has been suggestedI7 that the interferences found in evaluations of instruments can be displayed and compared graphically as 'interferographs'. Objective goals based on our formula could be added easily to such graphs (as lines parallel to the y-axis, viz, the amount of interferent added) to produce a rectangular 'area of accepatability'.
Carryover is an important performance characteristic and it has been stated that, with most systems, carryover is less than 1-2% and usually this will not cause significant errors in routine analytical results.lB However, since carryover, like interference, non-specificity and matrix effects, introduces a systematic error into an assay, the analytical goal proposed for interference might well also be applied to all of these characteristics. Indeed, if these other systematic sources of error (OE) were determined quantitatively during an evaluation, the general formula:
CV,<1.96 C V , + S E + C O E
could be used as an overall criterion of acceptability of a method.
